Derma Sciences Inc (NASDAQ:DSCI)

Delayed Data
As of 11:36am ET
 -0.01 / -0.12%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Other

Company Description

Derma Sciences, Inc. is a medical technology company, focused on wound care. The company operates through three segments: Pharmaceutical Wound Care, Advanced Wound Care and Traditional Wound Care. The Pharmaceutical Wound segment offers DSC127, a novel product for the treatment of diabetic foot ulcers. The Advanced Wound Care segment includes MEDIHONEY, BIOGUARD, ALGICELL AG, XTRASORB and TCC-EZ. The Traditional Wound Care segment consists of gauze sponges and bandages, non-adherent impregnated dressings, retention devices, paste bandages and other compression devices. It manufactures and markets adhesive bandages and related first aid products for the medical, industrial, private label and retail markets. The company also offers skin care products, which includes barrier creams and ointments, antibacterial cleansing foams and sprays, shampoos and body washes, hand sanitizers, bath additives, body oils and moisturizers to nursing homes, hospitals, home healthcare agencies and other institutions. Derma Sciences was founded on September 10, 1984 and is headquartered in Princeton, NJ

Contact Information

Derma Sciences, Inc.
214 Carnegie Center
Princeton New Jersey 08540
P:(609) 514-4744
Investor Relations:



Other institutional75.64%
Mutual fund holders25.35%
Individual stakeholders19.03%

Top Executives

Edward J. QuiltyChairman, President & Chief Executive Officer
Frederic EignerExecutive Vice President-Operations
John E. YetterChief Financial Officer & Executive Vice President
Barry J. WolfensonGroup President-Advanced Wound Care
Edward EisenlordVice President-Corporate Accounts

To view my watchlist

Not a member yet?

Sign up now for a free account